James Hippel
2021
In 2021, James Hippel earned a total compensation of $5M as Executive Vice President and CFO at Bio-Techne, a 59% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,095,156 |
|---|---|
| Option Awards | $2,724,928 |
| Salary | $600,500 |
| Stock Awards | $574,849 |
| Other | $9,445 |
| Total | $5,004,878 |
Hippel received $2.7M in option awards, accounting for 54% of the total pay in 2021.
Hippel also received $1.1M in non-equity incentive plan, $600.5K in salary, $574.8K in stock awards and $9.4K in other compensation.
Rankings
In 2021, James Hippel's compensation ranked 2,616th out of 12,415 executives tracked by ExecPay. In other words, Hippel earned more than 78.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,616 out of 12,415 | 79th |
Division Manufacturing | 1,035 out of 5,508 | 81st |
Major group Chemicals And Allied Products | 402 out of 2,378 | 83rd |
Industry group Drugs | 352 out of 2,099 | 83rd |
Industry Biological Products, Except Diagnostic Substances | 107 out of 449 | 76th |
Source: SEC filing on September 14, 2022.
Hippel's colleagues
We found four more compensation records of executives who worked with James Hippel at Bio-Techne in 2021.